share_log

博安生物:自願性公告度拉糖肽注射液(BA5101)在美國獲批開展臨床試驗

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIALSFOR DULAGLUTIDE INJECTION (BA5101) IN THE U.S.

HKEX ·  Aug 4, 2024 21:01
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more